These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 2969976

  • 21. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y, Suzuki Y, Suzuki E, Hayakawa H, Kimura K, Goto A, Omata M, Minamino N, Kangawa K, Matsuo H.
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [Abstract] [Full Text] [Related]

  • 22. Pressor responsiveness to intravenous quinpirole is blunted in malnourished, conscious rats: central vs. peripheral and spinal mechanisms.
    Lahlou S, Interaminense Lde F, Figueiredo AF, Duarte GP.
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):16-25. PubMed ID: 15175553
    [Abstract] [Full Text] [Related]

  • 23. Effect of vasopressin and V1 receptors blockade on hypotensive action of ANP in normotensive (WKY) and spontaneously hypertensive rats.
    Lapiński M, Stepniakowski K, Januszewicz A, Noszczyk B, Szczepańska-Sadowska E.
    J Physiol Pharmacol; 1992 Mar; 43(1):65-78. PubMed ID: 1450435
    [Abstract] [Full Text] [Related]

  • 24. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H, Wilson N, McNeill JR.
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I, Lorrain J, Di Paola ED, Lhoste F, Payen B, Dennis T, Scatton B.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [Abstract] [Full Text] [Related]

  • 26. Hyperresponsiveness of sympathoadrenal system in conscious DOCA-NaCl and SHR rats in response to acute hemorrhagic hypotension.
    Drolet G, de Champlain J.
    Clin Invest Med; 1992 Aug; 15(4):360-70. PubMed ID: 1516293
    [Abstract] [Full Text] [Related]

  • 27. Dopaminergic neuronal systems modulate the central cardiovascular effects of TRH in rats.
    Jedrusiak J, Brus R, Kostrzewa RM, Słowiński Z.
    Pol J Pharmacol; 1995 Aug; 47(1):43-52. PubMed ID: 7550548
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
    Moreau P, de Champlain J, Yamaguchi N.
    J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
    [Abstract] [Full Text] [Related]

  • 32. Interaction of vasopressin and of the atrial natriuretic peptide in blood pressure control.
    Szczepanska-Sadowska E.
    Acta Physiol Scand Suppl; 1989 Aug; 583():79-87. PubMed ID: 2530757
    [Abstract] [Full Text] [Related]

  • 33. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I, Lefèvre-Borg F, Gomeni R.
    J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
    [Abstract] [Full Text] [Related]

  • 34. Differential effects of phentolamine on the responsiveness of aortic and femoral smooth muscle from normotensive and DOCA/NaCl hypertensive rats.
    Soltis EE, Soltis TD, Katovich MJ, Field FP.
    Artery; 1986 Aug; 13(6):325-39. PubMed ID: 3778217
    [Abstract] [Full Text] [Related]

  • 35. Evidence for dopaminergic regulation of vasopressin release in the anephric rat.
    Hatzinikolaou P, Gavras H, North WG, Kohlmann O, Gavras I.
    J Hypertens; 1984 Jun; 2(3):311-5. PubMed ID: 6442313
    [Abstract] [Full Text] [Related]

  • 36. Renal atrial natriuretic peptide receptors binding properties and function are resistant to DOCA-salt-induced hypertension in rats.
    Li X, Woodard GE, Brown J, Rosado JA.
    Regul Pept; 2006 Dec 10; 137(3):114-20. PubMed ID: 16904201
    [Abstract] [Full Text] [Related]

  • 37. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats.
    Chen YF, Nagahama S, Winternitz SR, Oparil S.
    Am J Physiol; 1985 Jul 10; 249(1 Pt 2):H71-9. PubMed ID: 4014487
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
    Ni W, Fink GD, Watts SW.
    J Pharmacol Exp Ther; 2007 May 10; 321(2):485-91. PubMed ID: 17289838
    [Abstract] [Full Text] [Related]

  • 40. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
    Nuglozeh E, Gauquelin G, Garcia R, Tremblay J, Schiffrin EL.
    Am J Physiol; 1990 Jul 10; 259(1 Pt 2):F130-7. PubMed ID: 2165357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.